Page last updated: 2024-10-23

atenolol and Heart Defects, Congenital

atenolol has been researched along with Heart Defects, Congenital in 2 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, L1
Ng, A1
Chen, W1
Spencer, HT1
Nguyen, J1
Shen, AY1
Lee, MS1
Elias, J1
Valadão, W1
Kuniyoshi, R1
Queiroz, A1
Peixoto, CA1

Other Studies

2 other studies available for atenolol and Heart Defects, Congenital

ArticleYear
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
    JAMA internal medicine, 2017, 06-01, Volume: 177, Issue:6

    Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi

2017
Isolated noncompaction of the myocardium.
    Arquivos brasileiros de cardiologia, 2000, Volume: 74, Issue:3

    Topics: Adult; Anti-Arrhythmia Agents; Anticoagulants; Atenolol; Echocardiography, Doppler; Electrocardiogra

2000